Clinical trialObsRecruiting
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 23 June 2022
- Expected end
- October 2030
- Enrollment
- 500 participants
- Sites
- 3
- Primary outcomes
- Number of patients included in a pan-Canadian cohort with comprehensive clinical and genomic data
- Sponsor
- Other
- Results posted
- No
- Last update
- 10 June 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and lifestyle) to accelerate the discovery of innovations and improve the health outcomes for cancer patients
Detailed description public domain (ClinicalTrials.gov)
The purpose of this study is to use evolving technologies such as genomics and artificial intelligence to study cancer so that the right treatment can be given to the right patient, at the right time. Approximately 15,000 participants will take part in the greater MOHCCN study across Canada in the first 5 years, and ultimately the goal is to enroll up to 100,000 over next 10 years.